Randomized Trialhigh evidence
Patellar resurfacing in total knee replacement: 20-year clinical and economic results of a large multicentre, randomised controlled trial in the UK.
Lancet (London, England)·July 4, 2026·PMID 42309116
Why it mattersThis is the longest and largest RCT on patellar resurfacing, providing robust long-term data to guide surgical decision-making. The consistent trend favouring resurfacing across multiple endpoints, without additional cost, supports its routine use.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled